What radical AI upside looks like if everything goes right.
Powerful AI could compress a century of human progress
into a single decade.
A reading of Machines of Loving Grace
by Dario Amodei
Biology. Neuroscience. Economics.
Governance. Work. All resting on one foundation.
— when parallel experiments collapse timescales
If AI can run millions of parallel biological experiments — each one testing a different hypothesis, each one learning from the others — then the medical progress humanity expected across the entire 21st century could arrive in five to ten years. Not because the AI is smarter about biology. Because it can run the whole research process at datacenter scale.
Most companies are still using AI to analyze outputs — faster spreadsheets, pattern-matching on datasets you already have. Amodei is arguing for something different: AI that runs the whole research process. That designs experiments, interprets results, proposes next steps, iterates. The constraint is not intelligence anymore. The constraints are latency (how fast can you run experiments), data (what do you know), and physical laws (what is actually possible). Those constraints are real. But they are increasingly routable. The biggest wins come from finding the rare, high-impact discoveries — then compressing them across parallel instances. That is not a data-analysis problem. That is a research-direction problem.
The gap between narrow tool and full collaborator
is where most forecasts are still stuck.
A country of geniuses in a datacenter.
Running millions of parallel experiments
at once.
Most AI narratives split into two camps: utopian (AI solves everything) or dystopian (AI ruins everything). Amodei's essay does something rarer — it takes the upside seriously without being naive about constraints. The core insight is structural: intelligence has diminishing returns against hard constraints. You can have the smartest AI in the world, but if your experiments take six months to run, or if the data doesn't exist, or if the physics forbids it, intelligence alone doesn't compress time. But parallel instances of that intelligence do. A country of geniuses in a datacenter can run the experiment a million times simultaneously — each one learning from the others, each one proposing the next hypothesis. That is not intelligence as analysis. That is intelligence as research direction.
The five pillars he sketches — biology, neuroscience, economics, governance, work — are not speculative. They are domains where the bottleneck is discovery rate, not data availability or computational power. In biology, the rare breakthrough (a new protein fold, a disease mechanism) unlocks decades of follow-on work. In neuroscience, the same compression applies: mental illness, cognitive enhancement, expanded human baseline. In economics, the question is not whether AI can calculate — it is whether AI can design policy experiments and iterate toward better outcomes. Each domain has different constraints. Each domain has different upside. But the underlying logic is identical.
Where the essay is most honest: access and distribution are as strategically important as the breakthroughs themselves. An AI that cures cancer in a datacenter but the cure never reaches the poorest countries is not a humanitarian victory — it is a tragedy with better marketing. Amodei does not solve this problem. But he names it. That is rarer than it should be.
For founders, the implications are immediate. If you are building a research-adjacent tool — biotech, drug discovery, materials science, neuroscience, policy modeling — the question is not 'can AI analyze this better'. The question is 'can AI run the whole research loop'. Can it design the experiment, interpret the results, propose the next hypothesis, and iterate without human intervention? If yes, you are compressing timescales. If no, you are optimizing at the margins. The gap between those two is where most strategies are still stuck.
We read every message. No algorithm, no auto-reply — just Sophie and the LOOMUS team, with coffee, sometime this week.
Your note is in the inbox.
We'll write back when the kettle's on.
Saved with your account — part of a study that grows every time you distill. Nothing here expires, and nothing is lost.
Every LOOMUS reader may claim a planet — once, for life. It’s a slow choice, made when you’re ready.
Enter The Choosing →or simply look around your space →
No hurry; the sky holds your seat.